{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:21:09Z","timestamp":1790000469233,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T00:00:00Z","timestamp":1495756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T00:00:00Z","timestamp":1495756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Major Project of Gansu Province","award":["Grant No. 1203NKDA027"],"award-info":[{"award-number":["Grant No. 1203NKDA027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00705-017-3413-2","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T08:55:44Z","timestamp":1495788944000},"page":"2655-2665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Flagellin FljB as an adjuvant to the recombinant adenovirus rabies glycoprotein vaccine increases immune responses against rabies in mice"],"prefix":"10.1007","volume":"162","author":[{"given":"Xingxing","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaolin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,26]]},"reference":[{"key":"3413_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/0264-410X(92)90351-J","volume":"10","author":"M Artois","year":"1992","unstructured":"Artois M, Guittre C, Thomas I, Leblois H, Brochier B, Barrat J (1992) Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: a comparison. Vaccine 10:524\u2013528","journal-title":"Vaccine"},{"key":"3413_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1586\/14760584.6.6.939","volume":"6","author":"T Ben-Yedidia","year":"2007","unstructured":"Ben-Yedidia T, Arnon R (2007) Epitope-based vaccine against influenza. Expert Rev Vaccines 6:939\u2013948","journal-title":"Expert Rev Vaccines"},{"key":"3413_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.20506\/rst.7.4.383","volume":"7","author":"J Blancou","year":"1988","unstructured":"Blancou J, Pastoret P, Brochier B, Thomas I, Bogel K (1988) La vaccination antirabique des animaux sauvages. Rev Sci Tech Off Int Epiz 7:989\u20131003","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"3413_CR4","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.vaccine.2009.11.003","volume":"28","author":"CJ Braga","year":"2010","unstructured":"Braga CJ, Massis LM, Sbrogio-Almeida ME, Alencar BC, Bargieri DY, Boscardin SB, Rodrigues MM, Ferreira LC (2010) CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein. Vaccine 28:1373\u20131382","journal-title":"Vaccine"},{"key":"3413_CR5","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.vaccine.2013.12.015","volume":"32","author":"LJ Brown","year":"2014","unstructured":"Brown LJ, Rosatte RC, Fehlner-Gardiner C, Bachmann P, Ellison JA, Jackson FR, Taylor JS, Davies C, Donovan D (2014) Oral vaccination and protection of red foxes (Vulpes vulpes) against rabies using ONRAB, an adenovirus-rabies recombinant vaccine. Vaccine 32:984\u2013989","journal-title":"Vaccine"},{"key":"3413_CR6","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1128\/JVI.77.11.6305-6313.2003","volume":"77","author":"DR Casimiro","year":"2003","unstructured":"Casimiro DR, Chen L, Fu TM, Evans RK, Caulfield MJ, Davies ME, Tang A, Chen M, Huang L, Harris V, Freed DC, Wilson KA, Dubey S, Zhu DM, Nawrocki D, Mach H, Troutman R, Isopi L, Williams D, Hurni W, Xu Z, Smith JG, Wang S, Liu X, Guan L, Long R, Trigona W, Heidecker GJ, Perry HC, Persaud N, Toner TJ, Su Q, Liang X, Youil R, Chastain M, Bett AJ, Volkin DB, Emini EA, Shiver JW (2003) Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. J Virol 77:6305\u20136313","journal-title":"J Virol"},{"key":"3413_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF01317147","volume":"123","author":"KM Charlton","year":"1992","unstructured":"Charlton KM, Artois M, Prevec L, Campbell JB, Casey GA, Wandeler AI, Armstrong J (1992) Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Arch Virol 123:169\u2013179","journal-title":"Arch Virol"},{"key":"3413_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.vetmic.2011.12.014","volume":"157","author":"HC Chaung","year":"2012","unstructured":"Chaung HC, Cheng LT, Hung LH, Tsai PC, Skountzou I, Wang B, Compans RW, Lien YY (2012) Salmonella flagellin enhances mucosal immunity of avian influenza vaccine in chickens. Vet Microbiol 157:69\u201377","journal-title":"Vet Microbiol"},{"key":"3413_CR9","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1128\/IAI.72.5.2810-2816.2004","volume":"72","author":"C Cuadros","year":"2004","unstructured":"Cuadros C, Lopez-Hernandez FJ, Dominguez AL, McClelland M, Lustgarten J (2004) Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect Immun 72:2810\u20132816","journal-title":"Infect Immun"},{"key":"3413_CR10","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1002\/eji.200425403","volume":"34","author":"AF Cunningham","year":"2004","unstructured":"Cunningham AF, Khan M, Ball J, Toellner KM, Serre K, Mohr E, MacLennan IC (2004) Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1. Eur J Immunol 34:2986\u20132995","journal-title":"Eur J Immunol"},{"key":"3413_CR11","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.4049\/jimmunol.172.11.6922","volume":"172","author":"A Didierlaurent","year":"2004","unstructured":"Didierlaurent A, Ferrero I, Otten LA, Dubois B, Reinhardt M, Carlsen H, Blomhoff R, Akira S, Kraehenbuhl JP, Sirard JC (2004) Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J Immunol 172:6922\u20136930","journal-title":"J Immunol"},{"key":"3413_CR12","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.4049\/jimmunol.170.3.1416","volume":"170","author":"JC Fitzgerald","year":"2003","unstructured":"Fitzgerald JC, Gao GP, Reyes-Sandoval A, Pavlakis GN, Xiang ZQ, Wlazlo AP, Giles-Davis W, Wilson JM, Ertl HC (2003) A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. J Immunol 170:1416\u20131422","journal-title":"J Immunol"},{"key":"3413_CR13","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1128\/JVI.00519-11","volume":"85","author":"J Ge","year":"2011","unstructured":"Ge J, Wang X, Tao L, Wen Z, Feng N, Yang S, Xia X, Yang C, Chen H, Bu Z (2011) Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. J Virol 85:8241\u20138252","journal-title":"J Virol"},{"key":"3413_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/B978-0-7506-9265-6.50022-1","volume-title":"Vaccines: new approaches to immunological problems","author":"F Graham","year":"1992","unstructured":"Graham F, Prevec L (1992) Adenovirus-based expression vectors and recombinant vaccines. In: Ellis RW (ed) Vaccines: new approaches to immunological problems. Butterworth-Heinemann, Boston, pp 363\u2013390"},{"key":"3413_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7589\/0090-3558-43.1.124","volume":"43","author":"DA Grosenbaugh","year":"2007","unstructured":"Grosenbaugh DA, Maki JL, Rupprecht CE, Wall DK (2007) Rabies challenge of captive striped skunks (Mephitis mephitis) following oral administration of a live vaccinia-vectored rabies vaccine. J Wildl Dis 43:124\u2013128","journal-title":"J Wildl Dis"},{"key":"3413_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.rvsc.2013.05.001","volume":"95","author":"C Guo","year":"2013","unstructured":"Guo C, Zhang C, Zheng H, Huang Y (2013) Recombinant adenovirus expression of FMDV P1-2A and 3C protein and its immune response in mice. Res Vet Sci 95:736\u2013741","journal-title":"Res Vet Sci"},{"key":"3413_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099\u20131103","journal-title":"Nature"},{"key":"3413_CR18","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1016\/j.vaccine.2009.09.030","volume":"27","author":"H Henderson","year":"2009","unstructured":"Henderson H, Jackson F, Bean K, Panasuk B, Niezgoda M, Slate D, Li J, Dietzschold B, Mattis J, Rupprecht CE (2009) Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine. Vaccine 27:7194\u20137197","journal-title":"Vaccine"},{"key":"3413_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.vaccine.2011.10.058","volume":"30","author":"SH Hong","year":"2012","unstructured":"Hong SH, Byun YH, Nguyen CT, Kim SY, Seong BL, Park S, Woo GJ, Yoon Y, Koh JT, Fujihashi K, Rhee JH, Lee SE (2012) Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine 30:466\u2013474","journal-title":"Vaccine"},{"key":"3413_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1615\/CritRevImmunol.v20.i5.30","volume":"20","author":"T Kaisho","year":"2000","unstructured":"Kaisho T, Akira S (2000) Critical roles of Toll-like receptors in host defense. Crit Rev Immunol 20:393\u2013405","journal-title":"Crit Rev Immunol"},{"key":"3413_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/312163a0","volume":"312","author":"MP Kieny","year":"1984","unstructured":"Kieny MP, Lathe R, Drillien R, Spehner D, Skory S, Schmitt D, Wiktor T, Koprowski H, Lecocq JP (1984) Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312:163\u2013166","journal-title":"Nature"},{"key":"3413_CR22","doi-asserted-by":"publisher","first-page":"9693","DOI":"10.1128\/JVI.00823-14","volume":"88","author":"EH Kim","year":"2014","unstructured":"Kim EH, Park HJ, Han GY, Song MK, Pereboev A, Hong JS, Chang J, Byun YH, Seong BL, Nguyen HH (2014) Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice. J Virol 88:9693\u20139703","journal-title":"J Virol"},{"key":"3413_CR23","first-page":"18","volume":"9","author":"KJ Kresge","year":"2005","unstructured":"Kresge KJ (2005) Renewed promise. Annual AIDS vaccine meeting highlights recent data from clinical trials and lessons on recruitment and retention of volunteers. IAVI Rep 9:18\u201320","journal-title":"IAVI Rep"},{"key":"3413_CR24","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1371\/journal.pntd.0000626","volume":"4","author":"T Lembo","year":"2010","unstructured":"Lembo T, Hampson K, Kaare MT, Ernest E, Knobel D, Kazwala RR, Haydon DT, Cleaveland S (2010) The feasibility of canine rabies elimination in Africa: dispelling doubts with data. PLoS Negl Trop Dis 4:e626","journal-title":"PLoS Negl Trop Dis"},{"key":"3413_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.virol.2006.07.037","volume":"356","author":"J Li","year":"2006","unstructured":"Li J, Faber M, Papaneri A, Faber ML, McGettigan JP, Schnell MJ, Dietzschold B (2006) A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Virology 356:147\u2013154","journal-title":"Virology"},{"key":"3413_CR26","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.79.23.7415","volume":"79","author":"M Mackett","year":"1982","unstructured":"Mackett M, Smith GL, Moss B (1982) Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci USA 79:7415\u20137419","journal-title":"Proc Natl Acad Sci USA"},{"key":"3413_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1201-9712(00)90114-0","volume":"4","author":"L Martinez","year":"2000","unstructured":"Martinez L (2000) Global infectious disease surveillance. Int J Infect Dis 4:222\u2013228","journal-title":"Int J Infect Dis"},{"key":"3413_CR28","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1128\/IAI.68.10.5525-5529.2000","volume":"68","author":"PF McDermott","year":"2000","unstructured":"McDermott PF, Ciacci-Woolwine F, Snipes JA, Mizel SB (2000) High-affinity interaction between gram-negative flagellin and a cell surface polypeptide results in human monocyte activation. Infect Immun 68:5525\u20135529","journal-title":"Infect Immun"},{"key":"3413_CR29","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1086\/517613","volume":"195","author":"WF McDonald","year":"2007","unstructured":"McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, Price A, Jacobs A, Takahashi VN, Huang Y, Nakaar V, Alexopoulou L, Fikrig E, Powell TJ (2007) A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis 195:1607\u20131617","journal-title":"J Infect Dis"},{"key":"3413_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S1074-7613(02)00289-3","volume":"16","author":"SJ McSorley","year":"2002","unstructured":"McSorley SJ, Asch S, Costalonga M, Reinhardt RL, Jenkins MK (2002) Tracking salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity 16:365\u2013377","journal-title":"Immunity"},{"key":"3413_CR31","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.4049\/jimmunol.169.7.3914","volume":"169","author":"SJ McSorley","year":"2002","unstructured":"McSorley SJ, Ehst BD, Yu Y, Gewirtz AT (2002) Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo. J Immunol 169:3914\u20133919","journal-title":"J Immunol"},{"key":"3413_CR32","first-page":"1","volume":"187","author":"F Meslin","year":"1994","unstructured":"Meslin F, Fishbein D, Matter H (1994) Rationale and prospects for rabies elimination in developing countries. Curr Topics Microbiol Immunol 187:1","journal-title":"Curr Topics Microbiol Immunol"},{"key":"3413_CR33","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","volume":"185","author":"SB Mizel","year":"2010","unstructured":"Mizel SB, Bates JT (2010) Flagellin as an adjuvant: cellular mechanisms and potential. J Immunol 185:5677\u20135682","journal-title":"J Immunol"},{"key":"3413_CR34","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1073\/pnas.84.13.4626","volume":"84","author":"JE Morin","year":"1987","unstructured":"Morin JE, Lubeck MD, Barton JE, Conley AJ, Davis AR, Hung PP (1987) Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc Natl Acad Sci USA 84:4626\u20134630","journal-title":"Proc Natl Acad Sci USA"},{"key":"3413_CR35","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1016\/j.vaccine.2006.11.066","volume":"25","author":"H Poulet","year":"2007","unstructured":"Poulet H, Minke J, Pardo MC, Juillard V, Nordgren B, Audonnet JC (2007) Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform. Vaccine 25:5606\u20135612","journal-title":"Vaccine"},{"key":"3413_CR36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.7589\/0090-3558-45.2.363","volume":"45","author":"RC Rosatte","year":"2009","unstructured":"Rosatte RC, Donovan D, Davies JC, Allan M, Bachmann P, Stevenson B, Sobey K, Brown L, Silver A, Bennett K, Buchanan T, Bruce L, Gibson M, Beresford A, Beath A, Fehlner-Gardiner C, Lawson K (2009) Aerial distribution of ONRAB baits as a tactic to control rabies in raccoons and striped skunks in Ontario, Canada. J Wildl Dis 45:363\u2013374","journal-title":"J Wildl Dis"},{"key":"3413_CR37","doi-asserted-by":"publisher","first-page":"7947","DOI":"10.1073\/pnas.83.20.7947","volume":"83","author":"CE Rupprecht","year":"1986","unstructured":"Rupprecht CE, Wiktor TJ, Johnston DH, Hamir AN, Dietzschold B, Wunner WH, Glickman LT, Koprowski H (1986) Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc Natl Acad Sci U S A 83:7947\u20137950","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3413_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.7589\/0090-3558-26.1.99","volume":"26","author":"CE Rupprecht","year":"1990","unstructured":"Rupprecht CE, Charlton KM, Artois M, Casey GA, Webster WA, Campbell JB, Lawson KF, Schneider LG (1990) Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis). J Wildl Dis 26:99\u2013102","journal-title":"J Wildl Dis"},{"key":"3413_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1056\/NEJMoa010560","volume":"345","author":"CE Rupprecht","year":"2001","unstructured":"Rupprecht CE, Blass L, Smith K, Orciari LA, Niezgoda M, Whitfield SG, Gibbons RV, Guerra M, Hanlon CA (2001) Human infection due to recombinant vaccinia-rabies glycoprotein virus. N Engl J Med 345:582\u2013586","journal-title":"N Engl J Med"},{"key":"3413_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.virusres.2005.03.017","volume":"111","author":"CE Rupprecht","year":"2005","unstructured":"Rupprecht CE, Hanlon CA, Blanton J, Manangan J, Morrill P, Murphy S, Niezgoda M, Orciari LA, Schumacher CL, Dietzschold B (2005) Oral vaccination of dogs with recombinant rabies virus vaccines. Virus Res 111:101\u2013105","journal-title":"Virus Res"},{"issue":"Pt 2","key":"3413_CR41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1099\/0022-1317-70-2-417","volume":"70","author":"M Schneider","year":"1989","unstructured":"Schneider M, Graham FL, Prevec L (1989) Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. J Gen Virol 70(Pt 2):417\u2013427","journal-title":"J Gen Virol"},{"key":"3413_CR42","first-page":"113","volume":"4","author":"E Shen","year":"2007","unstructured":"Shen E, Li L, Li L, Feng L, Lu L, Yao Z, Lin H, Wu C (2007) PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA. Cell Mol Immunol 4:113\u2013120","journal-title":"Cell Mol Immunol"},{"key":"3413_CR43","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1016\/j.vaccine.2003.12.035","volume":"22","author":"L Strindelius","year":"2004","unstructured":"Strindelius L, Filler M, Sjoholm I (2004) Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H\/HeJ mice. Vaccine 22:3797\u20133808","journal-title":"Vaccine"},{"key":"3413_CR44","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","volume":"10","author":"N Tatsis","year":"2004","unstructured":"Tatsis N, Ertl HC (2004) Adenoviruses as vaccine vectors. Mol Ther 10:616\u2013629","journal-title":"Mol Ther"},{"key":"3413_CR45","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1016\/S0264-410X(00)00088-8","volume":"18","author":"T Tims","year":"2000","unstructured":"Tims T, Briggs DJ, Davis RD, Moore SM, Xiang Z, Ertl HC, Fu ZF (2000) Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies. Vaccine 18:2804\u20132807","journal-title":"Vaccine"},{"key":"3413_CR46","first-page":"363","volume":"51","author":"ND Tolson","year":"1987","unstructured":"Tolson ND, Charlton KM, Stewart RB, Campbell JB, Wiktor TJ (1987) Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Can J Vet Res 51:363\u2013366","journal-title":"Can J Vet Res"},{"key":"3413_CR47","first-page":"467","volume":"131","author":"N Tordo","year":"2008","unstructured":"Tordo N, Foumier A, Jallet C, Szelechowski M, Klonjkowski B, Eloit M (2008) Canine adenovirus based rabies vaccines. Dev Biol 131:467\u2013476","journal-title":"Dev Biol"},{"key":"3413_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1017\/S0950268899002666","volume":"123","author":"A Vos","year":"1999","unstructured":"Vos A, Neubert A, Aylan O, Schuster P, Pommerening E, Muller T, Chivatsi DC (1999) An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species. Epidemiol Infect 123:165\u2013175","journal-title":"Epidemiol Infect"},{"key":"3413_CR49","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1099\/0022-1317-82-9-2191","volume":"82","author":"A Vos","year":"2001","unstructured":"Vos A, Neubert A, Pommerening E, Muller T, Dohner L, Neubert L, Hughes K (2001) Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration. J Gen Virol 82:2191\u20132197","journal-title":"J Gen Virol"},{"key":"3413_CR50","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/jvi.71.5.3677-3683.1997","volume":"71","author":"Y Wang","year":"1997","unstructured":"Wang Y, Xiang Z, Pasquini S, Ertl HC (1997) The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus. J Virol 71:3677\u20133683","journal-title":"J Virol"},{"key":"3413_CR51","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1016\/j.vaccine.2007.02.084","volume":"25","author":"J Weyer","year":"2007","unstructured":"Weyer J, Rupprecht CE, Mans J, Viljoen GJ, Nel LH (2007) Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Vaccine 25:4213\u20134222","journal-title":"Vaccine"},{"key":"3413_CR52","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","volume":"81","author":"TJ Wiktor","year":"1984","unstructured":"Wiktor TJ, Macfarlan RI, Reagan KJ, Dietzschold B, Curtis PJ, Wunner WH, Kieny MP, Lathe R, Lecocq JP, Mackett M et al (1984) Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci USA 81:7194\u20137198","journal-title":"Proc Natl Acad Sci USA"},{"key":"3413_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/scientificamerican0692-86","volume":"266","author":"WG Winkler","year":"1992","unstructured":"Winkler WG, Bogel K (1992) Control of rabies in wildlife. Sci Am 266:86\u201392","journal-title":"Sci Am"},{"key":"3413_CR54","unstructured":"World Health Organization (2005) WHO Expert Consultation on Rabies. First report. (WHO technical report series, no. 931). World Health Organization, Geneva"},{"key":"3413_CR55","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1586\/erv.11.140","volume":"10","author":"X Wu","year":"2011","unstructured":"Wu X, Smith TG, Rupprecht CE (2011) From brain passage to cell adaptation: the road of human rabies vaccine development. Expert Rev Vaccines 10:1597\u20131608","journal-title":"Expert Rev Vaccines"},{"key":"3413_CR56","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1128\/JVI.76.6.2667-2675.2002","volume":"76","author":"Z Xiang","year":"2002","unstructured":"Xiang Z, Gao G, Reyes-Sandoval A, Cohen CJ, Li Y, Bergelson JM, Wilson JM, Ertl HC (2002) Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. J Virol 76:2667\u20132675","journal-title":"J Virol"},{"key":"3413_CR57","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1006\/viro.1996.0239","volume":"219","author":"ZQ Xiang","year":"1996","unstructured":"Xiang ZQ, Yang Y, Wilson JM, Ertl HC (1996) A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220\u2013227","journal-title":"Virology"},{"key":"3413_CR58","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1126\/science.322276","volume":"196","author":"J Zieg","year":"1977","unstructured":"Zieg J, Silverman M, Hilmen M, Simon M (1977) Recombinational switch for gene expression. Science 196:170\u2013172","journal-title":"Science"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-017-3413-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3413-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3413-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T22:31:23Z","timestamp":1744065083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-017-3413-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,26]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3413"],"URL":"https:\/\/doi.org\/10.1007\/s00705-017-3413-2","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,26]]},"assertion":[{"value":"19 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}